Re: CKD Reata / Market Cap
in response to
by
posted on
May 05, 2019 08:49PM
Koo,
I am cautiously optimistic that is the case. Processes such as trigylceride level decrease, membrane stabilisation, anithrombotic activity that are being labelled separate mechanisms are part of the cellular inflammation process and I believe the RVX drug does impact inflammation through all these individual processes.